ARCHIVES

ImClone “Screwed Up,” CEO Waksal Tells Conference; Stock Plunges.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Garfinkel to Retire From ACS; Health to Succeed Him

July 20, 1990

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

Court Filing By Fisher; Board, Attacks Interim NSABP Leadership

August 12, 1994

Senate Committee To Debate Budget Bill Sept. 10; Increase Expected For Breast Cancer Research

September 4, 1992

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

June 24, 1983

NCI Plans Conference On DES Late Effects, Reproductive Cancers

November 29, 1991